Integrative omics : concepts, methodology and application /
Provides a holistic and integrated view of defining and applying network approaches, integrative tools, and methods to solve problems for the rationalization of genotype to phenotype relationships. The reference provides systemic 'step-by-step' coverage that begins with basic concepts from...
| Corporate Author: | |
|---|---|
| Other Authors: | , , , |
| Format: | eBook |
| Language: | English |
| Published: |
London, United Kingdom : San Diego, CA :
Academic Press,
[2024]
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Front Cover
- Integrative Omics
- Integrative Omics: Concept, Methodology and Application
- Copyright
- Dedication
- Contents
- List of contributors
- Preface
- Organization of the book
- 1
- From omic to multi-integrative omics approach
- 1. Introduction
- 1.1 Omics
- 1.2 Genomics
- 1.3 Transcriptomics
- 1.4 Proteomics
- 1.5 Metabolomics
- 1.6 Epigenomics
- 1.7 Other potential omics
- 1.7.1 Fluxomics
- 1.7.2 Interactomics
- 1.7.3 Metagenomics
- 1.7.4 Pharmacogenomics
- 1.7.5 Phenomics
- 1.7.6 Foodomics
- 2. From omics to multi-integrative omics
- 3. Potential of multi-integrative omics
- 4. Integration and interdependencies of omics
- 4.1 Postanalysis data integration approaches
- 4.2 Integrated data analysis approaches
- 5. Data for multi-integrative omics
- 5.1 Multiomics data
- 5.2 Integration of multiomics data
- 6. Data mining and exploitation for omics data
- 7. Data mining tools/software
- 8. Integrative data mining challenges and possibilities
- 9. Scope for data science in multi-integrative omics
- 10. Conclusion
- References
- 2
- Types of omics data: Genomics, metagenomics, epigenomics, transcriptomics, proteomics, metabolomics, and phenom ...
- 1. Introduction
- 1.1 Genomics
- 1.2 Transcriptomics
- 1.3 Proteomics
- 1.4 Metabolomics
- 1.5 Epigenomics
- 2. Genomics in medicine
- 2.1 Current trends of genomics in medicine
- 2.1.1 Precision medicine
- 2.1.2 Pharmacogenomics
- 2.1.3 Genome editing
- 2.1.4 Gene therapy
- 2.2 Computational pipeline for genomics using R code
- 2.3 Applications of genomics
- 3. Metagenomics
- 3.1 Computational pipeline for metagenomics
- 3.2 Metagenomics omics tools and packages
- 4. Epigenomics
- 4.1 Publicly available datasets for epigenomics studies
- 4.1.1 The ENCODE project
- 4.1.2 The Roadmap Epigenomics project
- 4.1.3 The BLUEPRINT project.
- 4.1.4 The NIH Epigenomics Data Analysis and Coordination Center
- 4.1.5 The Gene Expression Omnibus
- 4.2 Epigenomics omics approaches
- 4.2.1 DNA methylation omics approaches
- 4.2.2 R code for DNA methylation data analysis pipeline
- 4.3 Epigenetic gene ontology and pathway analyses
- 4.4 Epigenomics databases
- 4.5 R codes for epigenomics data analysis
- 5. Transcriptomics
- 5.1 Transcriptomics studies in medicine
- 5.2 Publicly available transcriptomics datasets
- 5.2.1 GEO
- 5.2.2 The Cancer Genome Atlas
- 5.2.3 ArrayExpress
- 5.3 Transcriptomics computational pipelines
- 6. Proteomics
- 6.1 Omics approaches for proteomics
- 6.1.1 Quantitative proteomics
- 6.1.2 Structural proteomics
- 6.1.3 Posttranslational modification proteomics
- 6.1.4 Functional proteomics
- 7. Metabolomics
- 7.1 Types of metabolomics
- 7.1.1 Untargeted metabolomics
- 7.1.2 Targeted metabolomics
- 7.2 Various approaches commonly used in metabolomics
- 7.3 R codes for metabolomics pipeline
- 7.4 Publicly available metabolomics datasets
- 7.5 Application of omics-based metabolomics tools
- 8. Phenomics
- 8.1 Phenomics example datasets for using in R
- 8.2 Omics pipeline for phenomics analysis
- References
- 3
- Biological omics databases and tools
- 1. Introduction
- 2. Omics datasets study based on different technology
- 2.1 Next-generation sequencing
- 2.2 Microarray
- 2.3 RNA-Seq
- 2.4 Mass spectrometry
- 2.5 GC-MS (gas chromatography MS), LC-MS (liquid chromatography MS), and CE-MS (capillary electrophoresis MS)
- 3. Specific omics datasets based on sequencing approach
- 3.1 Genomics
- 3.2 Epigenomics
- 3.3 Metagenomics
- 3.4 Transcriptomics
- 3.5 Epitranscriptomics
- 4. Specific omics datasets based on MS approach
- 4.1 Proteomics
- 4.2 Epiproteomics
- 4.3 Metabolomics
- 4.4 Glycomics
- 4.5 Lipidomics.
- 5. Specific omics datasets based on knowledge
- 5.1 Microbiomics
- 5.2 Immunomics
- 6. Integration of omics datasets
- 6.1 Methods of integration of omics data
- 6.2 Techniques used for integration of multiomics data
- 6.2.1 Machine learning
- 6.2.2 Deep learning and its application in types of omics data
- 6.3 Biological tools and databases used in omics data analysis
- 6.4 Challenges of integration of omics data
- 6.5 Application of integrated omics data
- References
- 4
- Systematic benchmarking of omics computational tools
- 1. Introduction
- 2. Methodology for setting up the benchmarking study
- 2.1 Selection of reference model
- 2.2 Construction of gold standard dataset
- 2.3 Default parameters selection and optimization
- 2.4 Selection of benchmarking datasets
- 2.5 Selection of computational tools
- 2.6 Computational efficiency and scalability
- 2.7 Integration and interoperability
- 3. Experimental setup
- 3.1 QIAGEN Genomics Workbench
- 3.2 Partek Genomics Suite
- 3.3 Golden Helix
- 3.4 Genomatix
- 3.5 Biodatomics
- 3.6 Basepair
- 3.7 DNAnexus
- 3.8 Lasergene Genomics Suite
- 3.9 NextGENe
- 4. Case studies
- 4.1 Case study 1: Hybrid assembly strategy on genomics data analysis
- 4.1.1 Data collection
- 4.1.2 Genome assembly
- 4.1.3 Scaffolding
- 4.1.4 Metrics for quality control
- 4.1.5 Genome consistency plots
- 4.2 Case study 2: Computational cost analysis by assessing Oxford nanopore read assemblers
- 4.3 Case study 3: Genome assembly methods on metagenomic sequencing data
- 4.3.1 Metagenome assembly
- 4.3.2 Contig statistics
- 4.3.3 Contig binning and MAG qualities
- 4.3.4 Annotate MAGs into species
- 4.4 Case study 4: Data-independent acquisition mass spectrometry for immunopeptidomics
- 4.4.1 Library search-based DIA data analysis.
- 4.4.2 Software tools for peptide sequence and statistical data analysis
- 4.5 Case study 5: Long-read RNA-sequencing analysis tools using in silico mixtures
- 4.5.1 Long-read isoform detection
- 4.5.2 Transcript-level quantification of detected isoforms
- 4.5.3 Read count processing
- 4.5.4 Transcriptomic alignment
- 4.5.5 Differential transcript expression and usage analysis
- 5. The future of benchmarking challenges
- 6. Conclusion
- 7. Tools for omics data analysis
- References
- 5
- Pharmacogenomics, nutrigenomics, and microbial omics
- 1. Introduction
- 2. Pharmacogenomics
- 2.1 Why pharmacogenomics?
- 2.2 Discovery of pharmacogenomics
- 2.2.1 Cholinesterase inhibitors
- 2.2.2 Memantine
- 2.2.3 BACE inhibitors
- 2.3 The promise of pharmacogenomics
- 2.3.1 Personalized medicine
- 2.3.2 Drug selection and dosing
- 2.3.3 Adverse drug reactions
- 2.3.4 Drug development and clinical trials
- 2.3.5 Cost-effectiveness
- 2.4 Pharmacogenomics as a powerful tool
- 2.4.1 Improving the safety and effectiveness of medications
- 2.4.2 Reducing health-care costs
- 2.4.3 Improving the accuracy of clinical guidelines and treatment recommendations
- 2.4.4 Enhancing the understanding of the underlying causes of diseases
- 2.5 Pharmacogenomics-A solution
- 2.6 Role of pharmacogenomics in drug development
- 2.7 Research scopes in pharmacogenomics
- 2.7.1 Identifying genetic predictors of drug response
- 2.7.2 Investigating the role of genetic variation in adverse drug reactions
- 2.7.3 Exploring the use of pharmacogenomics in personalized medicine
- 2.7.4 Improving drug development and regulatory processes
- 3. Nutrigenomics
- 3.1 Why nutrigenomics?
- 3.2 Discovery of nutrigenomics
- 3.3 The promise of nutrigenomics
- 3.4 Nutrigenomics as a powerful tool
- 3.4.1 Personalized dietary recommendations.
- 3.4.2 Gene-nutrient interactions
- 3.4.3 Chronic disease prevention and management
- 3.4.4 Ethical considerations and challenges
- 3.5 Nutrigenomics as a solution
- 4. Microbial omics
- 4.1 Why microbial omics?
- 4.1.1 Metagenomics
- 4.1.2 Metatranscriptomics
- 4.1.3 Metaproteomics
- 4.1.4 Metabolomics
- 4.2 Discovery of microbial omics
- 4.2.1 Genomics
- 4.2.2 Metagenomics Fig. 5.2
- 4.2.3 Transcriptomics
- 4.2.4 Proteomics
- 4.2.5 Metabolomics
- 4.3 Promise of microbial omics
- 4.3.1 Genomics
- 4.3.2 Metagenomics
- 4.3.3 Transcriptomics
- 4.3.4 Proteomics
- 4.3.5 Metabolomics
- 5. Correlation between nutrigenomics, pharmacogenomics, and microbial omics
- References
- 6
- Proteomics: Present and future prospective
- 1. Introduction
- 2. Label-free quantitative proteomics
- 2.1 Relative quantification by peak intensity of LCMS
- 2.2 Relative quantification by spectral count
- 2.3 Absolute label-free quantification
- 2.4 Commercially available software for label-free quantitative proteomics
- 3. Techniques used in proteomics
- 3.1 Isotope coded affinity tag (ICAT) labeling
- 3.2 Stable isotope labeling with amino acids in cell culture (SILAC)
- 3.3 Isobaric tag for relative and absolute quantitation (iTRAQ)
- 3.4 2D gel electrophoresis
- 3.5 2D differential gel electrophoresis
- 3.6 Protein microarray
- 3.7 Reverse phased protein microarray
- 3.8 Mass spectrometry
- 3.9 LCMS/MS
- 3.10 MALDI TOF/TOF
- 3.11 NMR spectroscopy
- 4. Present prospective of proteomics
- 5. Future prospective of proteomics
- 6. Advance tools used for proteomics
- 7. Conclusion
- References
- 7
- Foodomics: Integrated omics for the food and nutrition science
- 1. Introduction
- 2. Major four areas of omics that are involved in foodomics are
- 2.1 Genomics
- 2.1.1 Nutritional genomics.